The Use of an Oral Mixture of Arginine, Glutamine and Beta-hydroxy-beta-methylbutyrate for Treatment of Pressure Ulcers
1 other identifier
interventional
90
1 country
1
Brief Summary
To investigate whether an oral nutritional supplement of a mixture of arginine, glutamine and HMB for a maximum period of four weeks is more beneficial than the standard dietary approach to the healing of pressure ulcers, and to examine whether the use of it can reduce admissions and length of hospitalizations for these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 28, 2017
CompletedFirst Posted
Study publicly available on registry
January 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedJanuary 31, 2017
January 1, 2017
2.8 years
January 28, 2017
January 30, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
percentage change in pressure ulcer area
4 weeks
change in Pressure Ulcer Scale for Healing (PUSH)
4 weeks
Secondary Outcomes (2)
number of hospital admissions
six months
length of hospitalisation
six months
Study Arms (2)
Study group
EXPERIMENTALThe treatment group would be given 2 Sackets of an oral mixture of arginine, glutamine and HMB (ABOUND) every day for a maximum period of 4 weeks, either orally or via enteral feeding.
Control group
NO INTERVENTIONAll patients would be assessed by a dietitian to ensure them receiving nutritional support of at least 30 kcal/kg/day and of at least 1.2 g/kg/day of protein regardless of feeding method. During the study period, vitamin C and zinc supplement would not be given.
Interventions
an oral mixture of arginine, glutamine and beta-hydroxy-beta-methylbutyrate
Eligibility Criteria
You may qualify if:
- Inpatients of medical and geriatric wards of OLMH and WTSH
- Aged 18 and older with stage III - IV lesions
- Patients fed orally or through feeding tubes were included
You may not qualify if:
- Patients with history of using the nutritional supplement (ABOUND) in previous three months
- Patients with cellulitis, wounds with purulent discharge or osteomyelitis or sepsis
- Patients requiring protein restriction
- Patients with poorly controlled diabetes mellitus (latest HbA1C \> 8.5) (healing process may be affected
- Patients under palliative care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Our Lady of Maryknoll Hospitallead
- Wong Tai Sin Hospitalcollaborator
Study Sites (1)
Our Lady of Maryknoll Hospital
Wong Tai Sin, 852, Hong Kong
Related Publications (3)
Cereda E, Gini A, Pedrolli C, Vanotti A. Disease-specific, versus standard, nutritional support for the treatment of pressure ulcers in institutionalized older adults: a randomized controlled trial. J Am Geriatr Soc. 2009 Aug;57(8):1395-402. doi: 10.1111/j.1532-5415.2009.02351.x. Epub 2009 Jun 25.
PMID: 19563522BACKGROUNDWong A, Chew A, Wang CM, Ong L, Zhang SH, Young S. The use of a specialised amino acid mixture for pressure ulcers: a placebo-controlled trial. J Wound Care. 2014 May;23(5):259-60, 262-4, 266-9. doi: 10.12968/jowc.2014.23.5.259.
PMID: 24810310BACKGROUNDCereda E, Klersy C, Serioli M, Crespi A, D'Andrea F; OligoElement Sore Trial Study Group. A nutritional formula enriched with arginine, zinc, and antioxidants for the healing of pressure ulcers: a randomized trial. Ann Intern Med. 2015 Feb 3;162(3):167-74. doi: 10.7326/M14-0696.
PMID: 25643304BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Ka Ying Doris Miu, FHKAM (Med)
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Consultant
Study Record Dates
First Submitted
January 28, 2017
First Posted
January 31, 2017
Study Start
December 1, 2016
Primary Completion
September 30, 2019
Study Completion
March 31, 2020
Last Updated
January 31, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share